Search Results

There are 13746 results for: content related to: Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling

  1. Assessing the appropriateness of combining economic data from multinational clinical trials

    Statistics in Medicine

    Volume 22, Issue 12, 30 June 2003, Pages: 1955–1976, John R. Cook, Michael Drummond, Henry Glick and Joseph F. Heyse

    Article first published online : 14 MAR 2003, DOI: 10.1002/sim.1389

  2. Using propensity scores to estimate the cost–effectiveness of medical therapies

    Statistics in Medicine

    Volume 25, Issue 9, 15 May 2006, Pages: 1561–1576, Alka Indurkhya, Nandita Mitra and Deborah Schrag

    Article first published online : 12 SEP 2005, DOI: 10.1002/sim.2267

  3. An illustration of the modelling of cost and efficacy data from a clinical trial

    Statistics in Medicine

    Volume 22, Issue 6, 30 March 2003, Pages: 1009–1024, Seokyung Hahn and Anne Whitehead

    Article first published online : 21 FEB 2003, DOI: 10.1002/sim.1459

  4. Incremental net benefit in randomized clinical trials

    Statistics in Medicine

    Volume 20, Issue 11, 15 June 2001, Pages: 1563–1574, Andrew R. Willan and D. Y. Lin

    Article first published online : 29 MAY 2001, DOI: 10.1002/sim.789

  5. Cost-effectiveness analysis when the WTA is greater than the WTP

    Statistics in Medicine

    Volume 20, Issue 21, 15 November 2001, Pages: 3251–3259, Andrew R. Willan, Bernie J. O'Brien and Rina A. Leyva

    Article first published online : 23 OCT 2001, DOI: 10.1002/sim.1018

  6. Cost–effectiveness analysis for multinational clinical trials

    Statistics in Medicine

    Volume 24, Issue 13, 15 July 2005, Pages: 1965–1982, Eleanor M. Pinto, Andrew R. Willan and Bernie J. O'Brien

    Article first published online : 1 APR 2005, DOI: 10.1002/sim.2078

  7. Statistical cost-effectiveness analysis of two treatments based on net health benefits

    Statistics in Medicine

    Volume 20, Issue 8, 30 April 2001, Pages: 1279–1302, Eugene M. Laska, Morris Meisner, Carole Siegel and Joseph Wanderling

    Article first published online : 6 APR 2001, DOI: 10.1002/sim.774

  8. Bayesian estimation of cost-effectiveness from censored data

    Statistics in Medicine

    Volume 23, Issue 8, 30 April 2004, Pages: 1297–1309, Daniel F. Heitjan, Clara Yuri Kim and Huiling Li

    Article first published online : 5 APR 2004, DOI: 10.1002/sim.1740

  9. Incremental net benefit in randomized clinical trials with quality-adjusted survival

    Statistics in Medicine

    Volume 22, Issue 3, 15 February 2003, Pages: 353–362, Andrew R. Willan, Eric Bingshu Chen, Richard J. Cook and D. Y. Lin

    Article first published online : 8 JAN 2003, DOI: 10.1002/sim.1347

  10. Regression methods for cost-effectiveness analysis with censored data

    Statistics in Medicine

    Volume 24, Issue 1, 15 January 2005, Pages: 131–145, Andrew R. Willan, D. Y. Lin and Andrea Manca

    Article first published online : 28 OCT 2004, DOI: 10.1002/sim.1794

  11. The value of information and optimal clinical trial design

    Statistics in Medicine

    Volume 24, Issue 12, 30 June 2005, Pages: 1791–1806, Andrew R. Willan and Eleanor M. Pinto

    Article first published online : 1 APR 2005, DOI: 10.1002/sim.2069

  12. The effect of outliers on confidence interval procedures for cost-effectiveness ratios

    Statistics in Medicine

    Volume 20, Issue 9-10, 15 - 30 May 2001, Pages: 1469–1477, Alka Indurkhya, Joseph C. Gardiner and Zhehui Luo

    Article first published online : 27 APR 2001, DOI: 10.1002/sim.683

  13. Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?

    Statistics in Medicine

    Volume 21, Issue 19, 15 October 2002, Pages: 2889–2897, Robert M. Califf

    Article first published online : 20 SEP 2002, DOI: 10.1002/sim.1293

  14. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data

    Statistics in Medicine

    Volume 23, Issue 7, 15 April 2004, Pages: 1075–1093, Patricia F. Moodie, Norma A. Nelson and Gary G. Koch

    Article first published online : 23 MAR 2004, DOI: 10.1002/sim.1696

  15. A Bayesian analysis of pharmacoeconomic data from a clinical trial on schizophrenia

    Statistics in Medicine

    Volume 22, Issue 6, 30 March 2003, Pages: 1025–1039, Claude Petit and Jean Maccario

    Article first published online : 21 FEB 2003, DOI: 10.1002/sim.1458

  16. Strengthening of moment-resisting frame structures against near-fault ground motion effects

    Earthquake Engineering & Structural Dynamics

    Volume 33, Issue 6, May 2004, Pages: 707–722, Babak Alavi and Helmut Krawinkler

    Article first published online : 13 FEB 2004, DOI: 10.1002/eqe.370

  17. Modelling intervention effects after cancer relapses

    Statistics in Medicine

    Volume 24, Issue 24, 30 December 2005, Pages: 3959–3975, Juan R. González, Edsel A. Peña and Elizabeth H. Slate

    Article first published online : 30 NOV 2005, DOI: 10.1002/sim.2394

  18. Economic evaluation in long-term clinical trials

    Statistics in Medicine

    Volume 21, Issue 19, 15 October 2002, Pages: 2879–2888, Mark A. Hlatky, Derek B. Boothroyd and Iain M. Johnstone

    Article first published online : 20 SEP 2002, DOI: 10.1002/sim.1292

  19. Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment

    Statistics in Medicine

    Volume 26, Issue 1, 15 January 2007, Pages: 110–123, Andrew C. Leon, Donald Hedeker and Jedediah J. Teres

    Article first published online : 12 DEC 2005, DOI: 10.1002/sim.2458

  20. A Markov model for sample size calculation and inference in vaccine cost-effectiveness studies

    Statistics in Medicine

    Volume 21, Issue 21, 15 November 2002, Pages: 3249–3260, G. B. Byrnes

    Article first published online : 7 OCT 2002, DOI: 10.1002/sim.1250